Preclinical development and a phase I trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer.

待确认 10 由小行星发布于 2026/3/14 19:17:35

DOI:10.1016/j.ymthe.2025.08.014
作者：Weijia Fang,Zhengmao Lu,Jingyu Ge,Shuangshuang Zhang,Rui Zheng,Weiwei Yin,Ruidong Hao,Minmin Sun,Tianhang Luo
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Autologous EpCAM-targeted CAR-T cell therapy (IMC001) was developed for advanced gastric cancer (GC). This study evaluated the specificity, efficacy, and safety of IMC001 in preclinical mode

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

1天前

你我没有ta

140afa6e1f9811f1bd3034735aa3bc31.pdf

1天前

Book学术机器人

2026/3/14 19:17:35 未找到该文献，机器人已退出，请等待人工下载

2026/3/14 19:17:35 Book学术AI机器人收到请求，开始寻找文献

2026/3/14 19:17:35 已向机器人发送请求

1天前

小行星发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierOnce-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes: main results from the STEP-HFpEF DM trial